Amlexanox

CHEMBL1096 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

298.3 g/mol

LogP

3.1

Phase

4

Originally developed as an anti-inflammatory and anti-allergic agent, this small molecule inhibits enzymes involved in inflammation to reduce swelling in oral tissues. Research has explored its potential to improve metabolic conditions such as obesity and fatty liver disease by targeting inflammatory pathways.

Masse moléculaire

298,2900 g/mol

LogP

3,10

TPSA

103,00 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Non-Alcoholic Fatty Liver Disease Obesity

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1

InChI

InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21)

Molecular Formula

C16H14N2O4

HBD / HBA

2 / 6

Liaisons Rotatives

2

Atomes Lourds

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Originally developed as an anti-inflammatory and anti-allergic agent, this small molecule inhibits enzymes involved in inflammation to reduce swelling in oral tissues. Research has explored its potential to improve metabolic conditions such as obesity and fatty liver disease by targeting inflammatory pathways.

Yes, Amlexanox is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1096. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 2161. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Amlexanox sur PillFYI

Structure

Données Clés

Formule: C16H14N2O4

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.